| 0.501 | 0.032 | 0.501 | Toll-Like receptor 7 agonist | | |
| 0.496 | 0.033 | 0.496 | Toll-Like receptor agonist | | |
| 0.449 | 0.007 | 0.449 | RET inhibitor | | |
| 0.403 | 0.004 | 0.403 | ALK inhibitor | | |
| 0.353 | 0.005 | 0.353 | Granulocyte macrophage colony stimulating factor antagonist | | |
| 0.37 | 0.033 | 0.37 | HERG channel blocker | | |
| 0.33 | 0.005 | 0.33 | AXL receptor tyrosine kinase inhibitor | | |
| 0.331 | 0.016 | 0.331 | Tyrosine-protein kinase receptor FLT3 inhibitor | | |
| 0.325 | 0.031 | 0.325 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | | |
| 0.328 | 0.041 | 0.328 | Potassium channel (Voltage-sensitive) blocker | | |
| 0.312 | 0.041 | 0.312 | Tyrosine kinase inhibitor | | |
| 0.245 | 0.005 | 0.245 | Syk tyrosine kinase inhibitor | | |
| 0.299 | 0.075 | 0.299 | Nootropic | | |
| 0.206 | 0.006 | 0.206 | Polo-like kinase-1 inhibitor | | |
| 0.237 | 0.049 | 0.237 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | | |
| 0.213 | 0.038 | 0.213 | Polo-like kinase-3 inhibitor | | |
| 0.19 | 0.025 | 0.19 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | | |
| 0.228 | 0.065 | 0.228 | MAP kinase kinase 2 inhibitor | | |
| 0.174 | 0.014 | 0.174 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | | |
| 0.232 | 0.075 | 0.232 | Potassium channel blocker | | |
| 0.168 | 0.015 | 0.168 | Leucine-rich repeat kinase 2 inhibitor | | |
| 0.294 | 0.146 | 0.294 | Analgesic | | |
| 0.167 | 0.02 | 0.167 | Protein kinase C mu inhibitor | | |
| 0.331 | 0.188 | 0.331 | Antiinflammatory | | |
| 0.161 | 0.019 | 0.161 | Insulin growth factor antagonist | | |
| 0.161 | 0.024 | 0.161 | Pim-1 kinase inhibitor | | |
| 0.242 | 0.114 | 0.242 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | | |
| 0.151 | 0.027 | 0.151 | Insulin receptor antagonist | | |
| 0.189 | 0.078 | 0.189 | Focal adhesion kinase 2 inhibitor | | |
| 0.208 | 0.1 | 0.208 | MAP kinase kinase 3 inhibitor | | |
| 0.136 | 0.039 | 0.136 | Alpha 2c adrenoreceptor antagonist | | |
| 0.123 | 0.028 | 0.123 | Insulin like growth factor 1 antagonist | | |
| 0.211 | 0.118 | 0.211 | 5 Hydroxytryptamine 1E antagonist | | |
| 0.155 | 0.063 | 0.155 | Activin receptor-like kinase 2 inhibitor | | |
| 0.109 | 0.018 | 0.109 | Polo-like kinase-2 inhibitor | | |
| 0.17 | 0.081 | 0.17 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | | |
| 0.11 | 0.021 | 0.11 | Phosphodiesterase 4B inhibitor | | |
| 0.171 | 0.083 | 0.171 | MAP kinase kinase 5 inhibitor | | |
| 0.176 | 0.091 | 0.176 | Death-associated protein kinase 3 inhibitor | | |
| 0.15 | 0.065 | 0.15 | Lck kinase inhibitor | | |
| 0.161 | 0.082 | 0.161 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | | |
| 0.093 | 0.014 | 0.093 | Autotaxin inhibitor | | |
| 0.11 | 0.035 | 0.11 | ErbB-3 antagonist | | |
| 0.092 | 0.02 | 0.092 | ZAP-70 protein tyrosine kinase inhibitor | | |
| 0.101 | 0.029 | 0.101 | Focal adhesion kinase 1 inhibitor | | |
| 0.121 | 0.053 | 0.121 | EphA2 antagonist | | |
| 0.151 | 0.083 | 0.151 | Src kinase inhibitor | | |
| 0.164 | 0.1 | 0.164 | Ca2+/calmodulin-dependent protein kinase inhibitor | | |
| 0.095 | 0.031 | 0.095 | Macrophage colony-stimulating factor 1 receptor antagonist | | |
| 0.105 | 0.042 | 0.105 | Acetylcholine M3 receptor agonist | | |
| 0.095 | 0.036 | 0.095 | Phosphodiesterase 11A inhibitor | | |
| 0.095 | 0.036 | 0.095 | Phosphodiesterase XI inhibitor | | |
| 0.115 | 0.061 | 0.115 | Polo-like kinase-4 inhibitor | | |
| 0.073 | 0.022 | 0.073 | Protein kinase C epsilon inhibitor | | |
| 0.145 | 0.095 | 0.145 | Protein kinase (CK1) gamma 3 inhibitor | | |
| 0.103 | 0.057 | 0.103 | MAP kinase 8 inhibitor | | |
| 0.071 | 0.031 | 0.071 | CDK4/cyclin D1 inhibitor | | |
| 0.086 | 0.048 | 0.086 | ErbB-4 antagonist | | |
| 0.082 | 0.046 | 0.082 | Janus tyrosine kinase 2 inhibitor | | |
| 0.089 | 0.054 | 0.089 | Epidermal growth factor antagonist | | |
| 0.078 | 0.043 | 0.078 | MAP3K7 inhibitor | | |
| 0.114 | 0.08 | 0.114 | MAP kinase kinase inhibitor | | |
| 0.132 | 0.1 | 0.132 | Cyclin-dependent kinase 8 inhibitor | | |
| 0.064 | 0.033 | 0.064 | CDK4/cyclin D inhibitor | | |
| 0.081 | 0.05 | 0.081 | MAP kinase 10 inhibitor | | |
| 0.063 | 0.032 | 0.063 | Bruton tyrosine kinase inhibitor | | |
| 0.117 | 0.086 | 0.117 | Ca2+/calmodulin-dependent kinase II delta inhibitor | | |
| 0.12 | 0.091 | 0.12 | Protein kinase (CK1) inhibitor | | |
| 0.065 | 0.036 | 0.065 | Janus tyrosine kinase 1 inhibitor | | |
| 0.09 | 0.062 | 0.09 | Antiadrenergic | | |
| 0.115 | 0.089 | 0.115 | Protein-tyrosine kinase Lyn inhibitor | | |
| 0.067 | 0.041 | 0.067 | Cyclin A2 inhibitor | | |
| 0.088 | 0.062 | 0.088 | Adrenaline antagonist | | |
| 0.119 | 0.093 | 0.119 | Growth factor antagonist | | |
| 0.061 | 0.035 | 0.061 | Protein kinase C theta inhibitor | | |
| 0.087 | 0.062 | 0.087 | CDK/cyclin complex inhibitor | | |
| 0.078 | 0.053 | 0.078 | MAP kinase 7 inhibitor | | |
| 0.17 | 0.148 | 0.17 | MAP-kinase-activated kinase 5 inhibitor | | |
| 0.123 | 0.104 | 0.123 | CC chemokine 6 receptor antagonist | | |
| 0.087 | 0.069 | 0.087 | Fibroblast growth factor 1 antagonist | | |
| 0.232 | 0.215 | 0.232 | MAP kinase kinase 6 inhibitor | | |
| 0.038 | 0.021 | 0.038 | ATM kinase inhibitor | | |
| 0.06 | 0.044 | 0.06 | Cyclin A inhibitor | | |
| 0.027 | 0.012 | 0.027 | Corticotropin releasing factor 1 receptor antagonist | | |
| 0.107 | 0.094 | 0.107 | Cyclin-dependent kinase 7 inhibitor | | |
| 0.119 | 0.108 | 0.119 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | | |
| 0.079 | 0.067 | 0.079 | Alpha 2 adrenoreceptor antagonist | | |
| 0.053 | 0.041 | 0.053 | Pim-2 kinase inhibitor | | |
| 0.096 | 0.087 | 0.096 | Aurora-B kinase inhibitor | | |
| 0.105 | 0.099 | 0.105 | Phosphodiesterase inhibitor | | |
| 0.061 | 0.055 | 0.061 | Cyclin B3 inhibitor | | |
| 0.071 | 0.066 | 0.071 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | | |
| 0.105 | 0.102 | 0.105 | Tyrosine-protein kinase receptor antagonist | | |
| 0.079 | 0.078 | 0.079 | Pim-3 kinase inhibitor | | |
| 0.051 | 0.05 | 0.051 | Fibroblast growth factor 4 antagonist | | |